PubMed - https://t.co/VJWtOdcsVt Interleukin-17-targeted treatment in patients with spondyloarthritis and associated cardiometabolic risk profile @HUCA_Asturias #publiHUCA #Rheumatology
1,613 followers
2,433 followers
Después del gym y una comida sana, una lectura tranquila pero interesante. IL17 y riesgo cardiovascular en pacientes con EspAs, por el Dr. Queiro. https://t.co/NqcyvVVdi5 en acceso abierto
68 followers
RT @FrontImmunol: New Research: Interleukin-17–targeted treatment in patients with spondyloarthritis and associated cardiometabolic risk pr…
155 followers
RT @FrontImmunol: New Research: Interleukin-17–targeted treatment in patients with spondyloarthritis and associated cardiometabolic risk pr…